Moomoo AI 已提取核心信息
RedHill Biopharma Ltd. has announced an extraordinary general meeting of shareholders to be held on March 20, 2024. The primary agenda for the meeting is to seek approval for an increase in the company's authorized share capital. The meeting will take place at the company's offices in Tel Aviv, Israel. Shareholders of record as of February 19, 2024, will be entitled to vote at the meeting. The Board of Directors has recommended a vote in favor of the proposal. Shareholders are urged to submit their proxies ahead of the meeting to ensure their shares are represented, with the option to revoke the proxy at any time before its exercise. The company has also provided a provision for shareholders to submit written statements...Show More
RedHill Biopharma Ltd. has announced an extraordinary general meeting of shareholders to be held on March 20, 2024. The primary agenda for the meeting is to seek approval for an increase in the company's authorized share capital. The meeting will take place at the company's offices in Tel Aviv, Israel. Shareholders of record as of February 19, 2024, will be entitled to vote at the meeting. The Board of Directors has recommended a vote in favor of the proposal. Shareholders are urged to submit their proxies ahead of the meeting to ensure their shares are represented, with the option to revoke the proxy at any time before its exercise. The company has also provided a provision for shareholders to submit written statements regarding their position on the agenda item by March 10, 2024. If a quorum is not present within half an hour of the appointed time, the meeting will be adjourned to the next business day. All relevant documents and proposed resolutions are available at the company's registered office and on its website, as well as on the SEC's website.
RedHill Biopharma Ltd.已宣布将于2024年3月20日举行特别股东大会。会议的主要议程是寻求批准增加公司的法定股本。会议将在该公司位于以色列特拉维夫的办公室举行。截至2024年2月19日的登记股东将有权在会议上投票。董事会建议对该提案投赞成票。敦促股东在会议之前提交委托书，以确保其股份得到代表，并可以选择在行使代理权之前随时撤销委托书。该公司还规定股东必须在2024年3月10日之前提交有关其在该议程项目上的立场的书面陈述。如果在指定时间后的半小时内未达到法定人数，会议将延期至下一个工作日。所有相关文件和拟议决议均可在公司的注册办事处及其网站以及美国证券交易委员会的网站上查阅。
RedHill Biopharma Ltd.已宣布将于2024年3月20日举行特别股东大会。会议的主要议程是寻求批准增加公司的法定股本。会议将在该公司位于以色列特拉维夫的办公室举行。截至2024年2月19日的登记股东将有权在会议上投票。董事会建议对该提案投赞成票。敦促股东在会议之前提交委托书，以确保其股份得到代表，并可以选择在行使代理权之前随时撤销委托书。该公司还规定股东必须在2024年3月10日之前提交有关其在该议程项目上的立场的书面陈述。如果在指定时间后的半小时内未达到法定人数，会议将延期至下一个工作日。所有相关文件和拟议决议均可在公司的注册办事处及其网站以及美国证券交易委员会的网站上查阅。
有用
没用